Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, No adverse event, Occupational exposure to product
Clinical narrative: what if some of the vaccine that spilled down the patients arm got into her eyes. The Pharmacist is not sure if this occurred but would like to know what to do if the bivalent vaccine got into her eye ?; Pharmacist is pregnant; No adverse event; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of OCCUPATIONAL EXPOSURE TO PRODUCT (what if some of the vaccine that spilled down the patients arm got into her eyes. The Pharmacist is not sure if this occurred but would like to know what to do if the bivalent vaccine got into her eye ?), MATERNAL EXPOSURE DURING PREGNANCY (Pharmacist is pregnant) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced OCCUPATIONAL EXPOSURE TO PRODUCT (what if some of the vaccine that spilled down the patients arm got into her eyes. The Pharmacist is not sure if this occurred but would like to know what to do if the bivalent vaccine got into her eye ?), MATERNAL EXPOSURE DURING PREGNANCY (Pharmacist is pregnant) and NO ADVERSE EVENT (No adverse event). At the time of the report, OCCUPATIONAL EXPOSURE TO PRODUCT (what if some of the vaccine that spilled down the patients arm got into her eyes. The Pharmacist is not sure if this occurred but would like to know what to do if the bivalent vaccine got into her eye ?), MATERNAL EXPOSURE DURING PREGNANCY (Pharmacist is pregnant) and NO ADVERSE EVENT (No adverse event) had resolved.        For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OCCUPATIONAL EXPOSURE TO PRODUCT (what if some of the vaccine that spilled down the patients arm got into her eyes. The Pharmacist is not sure if this occurred but would like to know what to do if the bivalent vaccine got into her eye ?) and MATERNAL EXPOSURE DURING PREGNANCY (Pharmacist is pregnant).    Concomitant and treatment medications were not provided.  Company comment:  This spontaneous case report concerns a 36-year-old female patient with no medical history provided. Reportedly, the patient in question was the pharmacist who administered mRNA-1273.222 vaccine (bivalent dose) to the another patient and as per provided information, about half of the vaccine squirt out of the syringe down the patient's arm. The patient (pharmacist) was worried whether the vaccine got into her eyes. At the time of this report, no adverse events were reported. Having in mind that the patient was pregnant, Maternal exposure during pregnancy was considered as an event, as per the most conservative approach. The benefit-risk relationship of the vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-641953 (Linked Report).; Sender's Comments: This spontaneous case report concerns a 36-year-old female patient with no medical history provided. Reportedly, the patient in question was the pharmacist who administered mRNA-1273.222 vaccine (bivalent dose) to the another patient and as per provided information, about half of the vaccine squirt out of the syringe down the patient's arm. The patient (pharmacist) was worried whether the vaccine got into her eyes. At the time of this report, no adverse events were reported. Having in mind that the patient was pregnant, Maternal exposure during pregnancy was considered as an event, as per the most conservative approach. The benefit-risk relationship of the vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-641953:Same reporter